$2.2m grant to support AI-driven sepsis program for pediatric care

Sepsis is a rapidly progressing, life-threatening condition characterized by organ dysfunction (OD) resulting from an immune response to infection.
Researchers at Children’s National Hospital are investigating pediatric sepsis, a leading cause of in-hospital death, particularly in underserved and minoritized populations.
A new Maximizing Investigators’ Research Award (MIRA) (R35) is granting over $2.2 million to Children’s National to establish a comprehensive sepsis program that will include a diagnostic artificial intelligence (AI) based, biomarker-enhanced platform for early recognition of pediatric sepsis and cutting-edge, extracellular vesicle-based therapeutics that can significantly decrease mortality and long-term disease sequelae.
MIRA provides support for research in an investigator’s laboratory that falls within the mission of The National Institute of General Medical Sciences.
Why it matters
Sepsis, defined as a rapidly progressive, is a life-threatening organ dysfunction (OD) due to an immune dysregulation as a response to infection. In the U.S., it results in over 75,000 pediatric admissions on an annual basis with an associated mortality rate of 5 to 20%.
“Sepsis has been linked to 20% of deaths worldwide and despite some recent advances in diagnostic tools, the lack of accurate definitions and heterogeneity of this clinical syndrome have led to delays in recognition and treatment with deleterious effects on the health of millions of children, especially those from minority groups,” says Ioannis Koutroulis, M.D., Ph.D., M.B.A., research director of Emergency Medicine at Children’s National. “Additionally, current sepsis therapeutic regimens are mostly supportive, lack the necessary personalization and fail to address the underlying physiological processes leading to sepsis-induced life threating organ failure.”
How does it move the field forward
High mortality rates and no significant new treatments in recent years due to sepsis presents a critical opportunity to make a global impact. Advancements in early recognition and intervention could save millions of lives. By utilizing AI and biomarkers for the early detection of sepsis in children, medical professionals could have the potential to greatly improve outcomes by enabling timely treatment.
“There is an urgent need to focus more attention on this condition and develop effective solutions to combat its devastating effects,” Dr. Koutroulis adds.
How we’re leading the way
The high-volume pediatric emergency room will serve as a crucial site for recruiting patients. With access to state-of-the-art laboratories, the research will be conducted in facilities equipped with cutting-edge technology, ensuring accurate and efficient analysis. This combination of a high patient volume and advanced research infrastructure will enable the program to deliver reliable results and make significant strides in the fight against pediatric sepsis.
“This grant will allow for early recognition of pediatric sepsis and treatment with an innovative approach using extracellular vesicle-based therapies that can directly affect immune and metabolic processes,” Dr. Koutroulis said.



In 2024, Children’s National Hospital continued to make remarkable strides across diverse areas of pediatric medicine, from groundbreaking technological innovations to critical health advocacy. The following compilation showcases ten significant stories that demonstrate the breadth and depth of the hospital’s impact, as featured in major national news outlets including NBC Nightly News, CNN, The Washington Post, The New York Times, NPR, The Today Show, Healio, and POLITICO. Delve into our 2024 news highlights for more.
2024 marked another groundbreaking year for Children’s National Hospital, showcasing remarkable advances across the spectrum of pediatric medicine, research and healthcare innovation. From pioneering surgical procedures to breakthrough artificial intelligence applications, the institution continued to push the boundaries of what’s possible in children’s healthcare. Read on for our list of the most popular articles we published on Innovation District in 2024.
Children’s National Hospital has expanded its class of 





Children’s National Hospital in Washington, D.C., was ranked as a top hospital in the nation by the 

Clinicians caring for children are often left to rely on off-label devices and medications approved for adults, especially during public health crises, national disasters and other emergencies. To address this critical gap, Children’s National Hospital is launching a 10-year partnership with the federal Biomedical Advanced Research and Development Authority (BARDA) — valued at $1.5 million per year, with the possibility of an additional funding boost of up to $515 million.





A new 









Advanced MRI visualization techniques to follow blood flow in the hearts of cardiac patients. Gene therapy for pediatric patients with Duchenne muscular dystrophy. 3D-printed casts for treating clubfoot. These were among the most popular articles we published on Innovation District in 2023. Read on for our full list.